NRXS CIK: 1933567

Neuraxis, INC

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
0.48
FY23:
0.97
FY23:
0.24
FY24:
4.27
FY25:
5.73
(positive)
Change from FY22 to FY25
millions USD
FY22:
1.00
FY23:
0.27
FY23:
0.27
FY24:
0.49
FY25:
0.67
Total assets
Change from FY22 to FY25
millions USD
FY22:
1.48
FY23:
1.24
FY23:
0.51
FY24:
4.76
FY25:
6.40

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
6.98
FY23:
2.26
FY23:
1.89
FY24:
2.43
FY25:
2.79
(negative)
Change from FY22 to FY25
millions USD
FY22:
0.08
FY23:
0.04
FY23:
0.03
FY24:
0.26
FY25:
0.21
(positive)
Change from FY22 to FY25
millions USD
FY22:
−5.57
FY23:
−1.06
FY23:
−1.40
FY24:
2.07
FY25:
3.40
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
1.48
FY23:
1.24
FY23:
0.51
FY24:
4.76
FY25:
6.40

All amounts in millions USD Data source:SEC EDGAR